在其他最近的新闻中，Edgewise Therapeutics一直是几家分析师公司和公司发展的焦点。Piper Sandler重申了增持评级，目标价为51美元，强调了即将到来的里程碑，如预计在3月底前发布的28天EDG-7500肥厚型心肌病数据。Scotiabank启动了跑赢大盘评级和50美元的目标价，引用Edgewise的药物候选品在走向商业化时实现显著销售的潜力。摩根大通将Edgewise ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report), with a ...

周五，渣打银行开始对Edgewise Therapeutics（NASDAQ:EWTX）进行研究覆盖，给予"板块超配"评级，目标价为每股50.00美元，显著高于当前28.13美元的交易价格。根据 InvestingPro ...

In a report released today, Laura Chico from Wedbush maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report), with a price ...

Wanting to escape the harried here and now, I opened T.H. White’s “The Once and Future King” I’d first read in 1958 at seventeen. I settled in to recapture ...

Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Edgewise Therapeutics (NasdaqGS:EWTX) with a Sector ...

BOULDER, Colo., March 11, 2025--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten ...

Such forward-looking statements include, among other things, statements regarding the potential of, and expectations regarding, Edgewise’s product candidates and programs, including sevasemten ...

Company to host an Industry Forum to discuss the lived experience of Becker and clinical advancements featuring a leading neuromuscular disease expert and a patient advocate – Edgewise is ...

BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten ...

In its fourth quarter 2024 investor letter, Baron Health Care Fund emphasized stocks such as Edgewise Therapeutics, Inc. (NASDAQ:EWTX). Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is a ...

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference – Company to host an Industry Forum to discuss ...